Sub-Community 伍素瑩 [53/74] 其他 [59/61] 夏克山 [77/157] 岳嶽 [29/34] 張仲明 [7/9] 張俊彥 [23/24] 張竣評 [21/38] 徐祖安 [170/241] 李秀珠 [76/108] 李靜琪 [24/28] 林書玉 [21/31] 洪明秀 [33/44] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/105] 童俊維 [25/25] 紀雅惠 [22/28] 翁紹華 [23/43] 莊宏 [1/1] 葉修華 [25/45] 葉燈光 [137/160] 蔣維棠 [43/99] 謝興邦 [180/261] 趙宇生(2002-2013) [120/279] 郭靜娟 [53/59] 鄒倫 [31/71] 陳志豪 [31/70] 陳新(2002-2015) [53/68] 陳炯東 [184/268] 顏婉菁 [6/8] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Siblings 分子與基因醫學研究所 [942/1007] 生醫工程與奈米醫學研究所 [1237/1432] 免疫醫學研究中心 [237/272] 神經及精神醫學研究中心 [825/878] 細胞及系統醫學研究所 [776/871] 感染症與疫苗研究所 [1577/1704] 群體健康科學研究所 [2942/3077] 癌症研究所 [2310/2499] 國家環境醫學研究所 [1592/1629] 國家蚊媒傳染病防治研究中心 [108/111] 高齡醫學暨健康福祉研究中心 [284/293] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [201/204] 核心儀器設施中心 [9/9] 病理核心實驗室 [15/15] 實驗動物中心 [9/9] 行政管理部門 [20/20] Community Statistics 近3年內發表的文件:121(10.02%) 含全文筆數:856(70.86%) 文件下載次數統計 下載大於0次:1614(188.55%) 下載大於100次:1548(180.84%) 檔案下載總次數:1004115(17.15%) 最後更新時間: 2025-05-02 08:09 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 KIF2C promotes paclitaxel resistanc... Identification of PTGR2 inhibitors ... Identification and biological evalu... Tumor cell-derived ISG15 promotes f... Nitrogen, oxygen, and sulphur heter... Prevotella intermedia protease inte... Upregulation of cathepsin S express... Orally bioavailable and site-select... Junceellolide Q, a new polyacetoxyb... Synthesis, anticancer evaluation an...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目461-470 / 1208. (共121頁) << < 42 43 44 45 46 47 48 49 50 51 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2017-01-13	Fused bicyclic pyrimidine compounds as aurora kinase inhibitors	IN279196/2017-01-13
2017-01	Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists	European Journal of Medicinal Chemistry. 2017 Jan;126:202-217.
2017-01	A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide	Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247.
2016-12-08	Bromomethylthioindole inspired carbazole hybrids as promising class of anti-MRSA agents	ACS Medicinal Chemistry Letters. 2016 Dec 8;7(12):1191-1196.
2016-12	Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation	Oncotarget. 2016 Dec;7(52):86239-86256.
2016-12	Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer	Oncotarget. 2016 Dec;7(52):85917-85928.
2016-12	Phenyl benzenesulfonylhydrazides: Selective indoleamine 2,3-dioxygenase inhibitors with potent in vivo pharmacodynamic activity and antitumor efficacy	European Journal of Cancer. 2016 Dec;68(Suppl. 1):S83-S84.
2016-12	Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST	Annals of Oncology. 2016 Dec;27(Suppl. 9):Meeting Abstract 2P.
2016-11-29	Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design	European Journal of Medicinal Chemistry. 2016 Nov 29;124:186-199.
2016-11-23	吡唑類化合物	J/002325/2016-11-23

顯示項目461-470 / 1208. (共121頁) << < 42 43 44 45 46 47 48 49 50 51 > >> 每頁顯示[10|25|50]項目